Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Biofrontera (BFRIW) over the last 5 years, with Q3 2025 value amounting to -$0.62.

  • Biofrontera's EPS (Weighted Average and Diluted) rose 3673.47% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 33281.25%. This contributed to the annual value of -$3.22 for FY2024, which is 7527.38% up from last year.
  • Biofrontera's EPS (Weighted Average and Diluted) amounted to -$0.62 in Q3 2025, which was up 3673.47% from -$0.57 recorded in Q2 2025.
  • Biofrontera's 5-year EPS (Weighted Average and Diluted) high stood at $4.55 for Q4 2023, and its period low was -$7.23 during Q2 2023.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.76 (2022), whereas its average is -$1.52.
  • Over the last 5 years, Biofrontera's EPS (Weighted Average and Diluted) had its largest YoY gain of 26250.0% in 2023, and its largest YoY loss of 185053.37% in 2023.
  • Over the past 5 years, Biofrontera's EPS (Weighted Average and Diluted) (Quarter) stood at -$2.0 in 2021, then tumbled by 40.0% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then plummeted by 105.56% to -$0.25 in 2024, then crashed by 144.99% to -$0.62 in 2025.
  • Its last three reported values are -$0.62 in Q3 2025, -$0.57 for Q2 2025, and -$0.47 during Q1 2025.